35 completed, 6 withdrawn, 3 recruiting, 3 unknown. 13 Phase 2, 13 Phase 4, 11 Phase 3, 9 Phase 1, 7 Not applicable.
Follow Testosterone Gel: new trials by email Literature Review of Testosterone Gel trials Research Report on Testosterone Gel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Testosterone Enanthate, Testosterone Cypionate, Testosterone Propionate - Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes | Not applicable | Enrolling by invitation | Enhanced Emirates Limited | 60 | 2026-03-12 | 2026-05-06 |
| Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration Testosterone injection, Testosterone gel, Testosterone Oral - Healthy | Early Phase 1 | Completed | Sports Medicine Research and Testing Laboratory | 14 | 2024-11-27 | 2024-12-03 |
| Klinefelter Syndrome and Testosterone Treatment in Puberty Testosterone gel, Placebo - Klinefelter Syndrome | Phase 4 | Recruiting | Lise Aksglæde | 32 | 2024-08-15 | 2025-02-19 |
| Brain Blood Flow Responses to Stress: Sex Differences Indomethacin, Placebo, Orilissa - Cerebrovascular Disorders | Phase 4 | Completed | University of Wisconsin, Madison | 22 | 2024-07-24 | 2026-09-24 |
| Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome Anastrozole, Semaglutide, human chorionic gonadotropin - Klinefelter Syndrome | Phase 3 | Recruiting | Georgios Papadakis | 150 | 2023-03-21 | 2026-05-11 |
| Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy Testosterone gel, Placebo - Prostatic Neoplasms, Hypogonadism | Phase 3 | Recruiting | Canisius-Wilhelmina Hospital | 140 | 2022-12-12 | 2025-05-02 |
| Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study Testosterone gel, Placebo - Disorder of Sex Development, 46,XY | Phase 3 | Unknown | Erasmus Medical Center | 1 | 2021-06-01 | 2021-04-05 |
| Testosterone and Neurovascular Control in Humans Cetrorelix Acetate, Testosterone gel - Healthy | Not applicable | Unknown | Western University, Canada | 20 | 2021-06-01 | 2021-03-26 |
| A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism Aveed Injectable Product, Fortesta, Testim - Hypogonadism, Hypogonadism, Male | Phase 4 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 673 | 2020-06-30 | 2025-03-14 |
| A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism AndroGel 1.62% - Hypogonadism | Phase 4 | Completed | AbbVie | 246 | 2020-05-12 | 2022-12-15 |
| ITT-5 Mechanisms of Spermatogenesis in Man Testosterone 1% Gel, Acyline, Dutasteride - Gonadotropin Deficiency | Phase 2 | Withdrawn | University of Washington | 2019-06-01 | 2019-12-18 | |
| Steroid Profile: Differentiating Testosterone Administration From (Simultaneous) Ethanol Consumption Testosterone gel, Ethanol Solution, Testosterone placebo (vaseline) - Healthy Volunteers | Phase 1 | Completed | Parc de Salut Mar | 4 | 2019-05-06 | 2019-11-18 |
| Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters. Testosterone gel, Estradiol ovules, Moisturizer - Hypoactive Sexual Desire Disorder, Vulvovaginal Disease | Completed | University of Florence | 81 | 2019-03-20 | 2020-04-07 | |
| Effect of Testosterone Pretreatment in POR Testosterone gel - Infertility | Not applicable | Completed | Hanoi Medical University | 165 | 2018-02-16 | 2020-10-26 |
| Periodontal Profile of Hypogonadic Men Testosterone gel, Placebos - Periodontitis, Hypogonadism, Male | Phase 4 | Withdrawn | Universidade Federal do Paraná | 2017-05-01 | 2020-04-16 | |
| Transdermal Testosterone for Poor Responder Patients Undergoing Controlled Ovarian Stimulation Prior to IVF Testosterone gel - Infertility, Female | Phase 4 | Unknown | Wolfson Medical Center | 30 | 2017-03-01 | 2017-03-13 |
| Cardiovascular Outcomes of Low Testosterone Acyline, Placebo Gel, Placebo Tablet - Hypogonadism | Not applicable | Completed | University of Colorado, Denver | 232 | 2016-07-01 | 2024-10-10 |
| Testosterone Gel in Poor Responders Undergoing IVF Testosterone gel, DHEA - Infertility | Not applicable | Withdrawn | Vietnam National University | 2015-09-01 | 2017-04-18 | |
| Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial Testosterone gel, Placebo gel - Infertility, Poor Ovarian Response | Phase 3 | Terminated | Fundacion Dexeus | 290 | 2015-04-01 | 2024-05-22 |
| Testosterone and Pain Sensitivity Testosterone Gel, Placebo Gel - Low Testosterone, Hypogonadism | Phase 4 | Withdrawn | Johns Hopkins University | 2012-08-01 | 2015-03-31 |
Showing 20 of 50. Sign in to see all of them.
Hypogonadism (16) · Infertility (4) · Sexual Dysfunctions, Psychological (4) · Diabetes Mellitus (3) · Metabolic Syndrome (3) · Pain (3) · Depression (2) · Erectile Dysfunction (2) · Eunuchism (2) · Insulin Resistance (2) · Klinefelter Syndrome (2) · Prostatic Neoplasms (2) · Alzheimer Disease (1) · Anemia (1) · Breast Neoplasms (1)
University of Washington (11) · BioSante Pharmaceuticals (3) · Boston University (2) · Repros Therapeutics Inc. (2) · University of Colorado, Denver (2) · AbbVie (1) · Canisius-Wilhelmina Hospital (1) · Diabetes Center of the Southwest (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · Enhanced Emirates Limited (1) · Erasmus Medical Center (1) · Fundacion Dexeus (1) · Georgios Papadakis (1) · Hanoi Medical University (1) · James J. Peters Veterans Affairs Medical Center (1)
United States (31) · Canada (4) · Denmark (2) · Israel (2) · Netherlands (2) · Spain (2) · Switzerland (2) · Vietnam (2) · Belgium (1) · Brazil (1) · France (1) · Italy (1) · United Arab Emirates (1)
Michael C Snabes, MD, PhD (3) · William J Bremner, MD, PhD (3) · Alvin M Matsumoto, MD (1) · Ana M Aldea Perona, Dr (1) · Christina Wang, MD (1) · Christopher P Cardozo, M.D. (1) · Dana Rathkopf, MD, PhD (1) · Daniel Bessesen, MD (1)
PMID 38224135, PMID 17494097, PMID 16352669, PMID 16882745, PMID 16940442, PMID 17303493, PMID 17510436, PMID 19366848, PMID 19653976, PMID 20484472, PMID 20520285, PMID 21575967, PMID 21761342, PMID 21797916, PMID 22172433, PMID 22266332, PMID 23040523, PMID 23165659, PMID 23348398, PMID 23494931, PMID 24106072, PMID 25548978, PMID 25599449, PMID 26554661, PMID 26886521, PMID 27355400, PMID 27992261, PMID 28241231, PMID 28241237, PMID 28241355, PMID 28241356, PMID 28981994, PMID 29253154, PMID 29380951, PMID 30366567, PMID 31784747, PMID 32785689, PMID 34118018, PMID 35041751, PMID 35790332, PMID 39385523, PMID 40090688, PMID 40514343, PMID 41461161, PMID 41680203
U54HD042454 (3), U54HD012629 (2), 2014 (1), 2023 (1), R01AG027156 (1), R01AG037679 (1), R01AG049762 (1), R01HD047722 (1), R01HL150361 (1)